Invitation to Cosmo’s Half-Year 2022 Results Webcast on 28 July 2022
Cosmo develops and manufactures products which are distributed globally by selected partners including Lialda, Uceris/Cortiment and Winlevi.
- Cosmo develops and manufactures products which are distributed globally by selected partners including Lialda, Uceris/Cortiment and Winlevi.
- Cosmo has also developed medical devices for endoscopy and has a partnership with Medtronic for the global distribution of GI Genius which uses artificial intelligence to help detect potential signs of colon cancer.
- Cosmo has licensed Aemcolo to Red Hill Biopharma Ltd. for the US and has licensed Relafalk to Dr. Falk Gmbh for the EU and other countries.
- Cosmo does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such statements.